NeuroOne Medical Technologies Corporation

NMTC

NASDAQ

Healthcare

Medical - Devices

Eden Prairie, MN, US17 employeesn1mtc.com

$0.80

-0.00(-0.54%)

Mkt Cap $40M

$0.43

$1.06

52-Week Range

At a Glance

AI-generated

8-K

NeuroOne Medical Technologies Corporation stockholders approved amendments to its 2025 Equity Incentive Plan increasing the share reserve by 1,500,000 shares and adding annual evergreen increases, elected two Class III directors, ratified the auditor, and approved a reverse stock split at the April 3, 2026 Annual Meeting.

$40M

Market Cap

$9M

Revenue

-$7M

Net Income

Employees17

Fundamentals

How The Business Makes Money

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.

Industry Medical - Devices

Activity

What Changed Recently

Management Change

Apr 2, 2026

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.** On Februa

Financial Results

Feb 16, 2026

of this Current Report, including Exhibit 99.1 hereto, is furnished pursuant to Item 2.02 and shall not be deemed “filed” for purposes of Section 18 of the Secu

Other Event

Feb 24, 2026

Other Items. The Board of Directors of NeuroOne Medical Technologies Corporation (the “Company”) has established April 3, 2026 as the date of the Company’s 2026

Peer Companies

Company	Price	Change	Market Cap	P/E
BDMDBaird Medical Investment ...	$1.89	-0.53%	$69M	-18.8
YI111, Inc.	$6.52	-1.51%	$57M	-5.7
ECORelectroCore, Inc.	$6.80	+3.03%	$55M	—
CTSOCytosorbents Corporation	$0.58	+5.13%	$36M	-4.0
STRRStar Equity Holdings, Inc...	$9.72	+3.40%	$36M	-6.4
ATHEAlterity Therapeutics Lim...	$3.56	-2.22%	$32M	-5.6
MYOMyomo, Inc.	$0.67	-0.83%	$26M	—
HYPDHyperion DeFi, Inc.	$3.23	-1.22%	$16M	-0.1

Analyst View

Company Profile

CIK0001500198

ISINUS64130M2098

CUSIP64130M209

Phone952 426 1383

Address7599 Anagram Drive, Eden Prairie, MN, 55344, US

SEC EDGAR